Search Results - Manges, Robert F.

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
    Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

    Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial by Nowakowski, Grzegorz S., Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S., Patel, Krish, Jäger, Ulrich, Manges, Robert F., Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell’Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    A phase 2 multicentre study of siltuximab, an anti‐interleukin‐6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma

    A phase 2 multicentre study of siltuximab, an anti‐interleukin‐6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma by Voorhees, Peter M., Manges, Robert F., Sonneveld, Pieter, Jagannath, Sundar, Somlo, George, Krishnan, Amrita, Lentzsch, Suzanne, Frank, Richard C., Zweegman, Sonja, Wijermans, Pierre W., Orlowski, Robert Z., Kranenburg, Britte, Hall, Brett, Casneuf, Tineke, Qin, Xiang, Velde, Helgi, Xie, Hong, Thomas, Sheeba K.

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial

    Safety and efficacy of durvalumab with R-CHOP or R 2 -CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial by Nowakowski, Grzegorz S, Willenbacher, Wolfgang, Greil, Richard, Larsen, Thomas S, Patel, Krish, Jäger, Ulrich, Manges, Robert F, Trümper, Lorenz, Everaus, Hele, Kalakonda, Nagesh, Brown, Peter, Jørgensen, Judit Meszaros, Cunningham, David, Dell'Aringa, Justine, Fox, Brian, Rubio, Neus Domper, Kilavuz, Nurgul, Casadebaig, Marie-Laure, Manzke, Oliver, Munoz, Javier

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    A Phase 2 Multicenter Study of Siltuximab, An Anti-IL-6 Monoclonal Antibody, in Patients with Relapsed or Refractory Multiple Myeloma

    A Phase 2 Multicenter Study of Siltuximab, An Anti-IL-6 Monoclonal Antibody, in Patients with Relapsed or Refractory Multiple Myeloma by Voorhees, Peter M., Manges, Robert F, Sonneveld, Pieter, Jagannath, Sundar, Somlo, George, Krishnan, Amrita, Lentzsch, Suzanne, Frank, Richard C, Zweegman, Sonja, Wijermans, P.W., Rijnbeek, Britte, Qin, Xiang, Cornfeld, Mark J., Xie, Hong, Thomas, Sheeba K.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Phase 3b UPFRONT Study: Interim Results From a Community Practice-Based Prospective Randomized Trial Evaluating Three Bortezomib-Based Regimens in Elderly, Newly Diagnosed Multiple Myeloma Patients

    Phase 3b UPFRONT Study: Interim Results From a Community Practice-Based Prospective Randomized Trial Evaluating Three Bortezomib-Based Regimens in Elderly, Newly Diagnosed Multiple... by Niesvizky, Ruben, Reeves, James, Flinn, Ian W, Rifkin, Robert M., Clowney, Billy, Gabrail, Nashat, Phooshkooru, Vijay R., Charu, Veena, Chay, Christopher H., Corzo, Deyanira, Neuwirth, Rachel, Manges, Robert F., Warr, Thomas A.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma

    Preliminary Results of CNTO 328, an Anti-Interleukin (IL)-6 Monoclonal Antibody (mAb), in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma by Manges, Robert F., Sutherland, Heather J., Jagannath, Sundar, Orlowski, Robert Z., La Police, David, DeWitte, Mark, Lang, Zhihui, Corringham, Robert E., Rossi, Jean Francois

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Preliminary Results of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody, in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma

    Preliminary Results of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody, in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma by Rossi, Jean-Francois, Manges, Robert F., Sutherland, Heather J., Jagannath, Sundar, Voorhees, Peter, Sonneveld, Pieter, Delforge, Michel, Pegourie, Brigitte, Alegre, Adrian, de la Rubia, Javier, La Police, David, Bandekar, Rajesh, Xie, Hong, Orlowski, Robert Z.

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  8. 8
    Plasma Concentrations of Hepcidin in Anemic Zimbabwean Infants

    Plasma Concentrations of Hepcidin in Anemic Zimbabwean Infants by Mupfudze, Tatenda G, Stoltzfus, Rebecca J, Rukobo, Sandra, Moulton, Lawrence H, Humphrey, Jean H, Prendergast, Andrew J, Jones, Andrew D, Manges, Amee, Mangwadu, Goldberg, Maluccio, John A, Mbuya, Mduduzi N N, Ntozini, Robert, Tielsch, James M

    Published in PloS one
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: